The high-grade diagnoses of BRCA-related ovarian cancer, exceeding 70%, and the lack of correlation between cancer grade and age at diagnosis highlight the urgency of understanding the impact of BRCA1-BRCT domain mutations in the context of ovarian cancer susceptibility. This evidence concerns the gene BRCA1 and ovarian cancer.